Sally Crossing AM Award for an Outstanding Outcome in Cancer Research
This Award is dedicated to the memory of the late Sally Crossing AM (1946-2016). Sally was a pioneer and tireless advocate for consumer involvement in cancer research. Cancer Council NSW and Cancer Voices NSW acknowledge the extraordinary support of the Belalberi Foundation and the Crossing family in conferring this award.
The Sally Crossing AM Award for an Outstanding Outcome in Cancer Research (individual award) rewards outstanding achievement in cancer research, the inclusion of consumers in research, and the delivery of significant benefit to the cancer community.
The award recipient will receive $50,000 to further their research endeavours.
The Sally Crossing AM Award for an Outstanding Outcome in Cancer Research will recognise a researcher who satisfies the following criteria:
- Received Cancer Council NSW competitive research funding as lead chief investigator (Chief Investigator A), within 10 years of award.*
- Has achieved a significant outcome in the field of cancer research that benefits the community and can be attributed to Cancer Council NSW funding
- Involved consumers (a person affected by cancer or a member of the general community) in the research that led to the outcome, and
- Is an active cancer researcher affiliated with an NHMRC administering institution.
* Including grants awarded through the Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (funded in part/full by Cancer Council NSW).
All nominations must be submitted using the online nomination form below.
Applications open for 2022.
Researchers are to self-nominate for the award and must address the eligibility criteria.
To assist in your preparation, you can preview the Nomination Form questions.
Enquiries can be directed to email@example.com.